Diagnostic Approach for Memory Loss and Paresthesias

Immediate Diagnostic Priorities

The American Academy of Neurology recommends obtaining vitamin B12 level, homocysteine, complete blood count, comprehensive metabolic panel, thyroid function, erythrocyte sedimentation rate, and C-reactive protein to assess for reversible causes of memory loss and paresthesias 1
Vitamin B12 deficiency is a critical reversible cause that presents with both memory impairment and peripheral neuropathy, making it a likely unifying diagnosis for this symptom constellation 1
Evaluation for diabetes is necessary, as it represents both a vascular risk factor for cognitive decline and a common cause of peripheral neuropathy 2, 1

The Alzheimer's Association recommends conducting validated neuropsychological testing using Montreal Cognitive Assessment (MoCA), which is more sensitive than MMSE for detecting mild cognitive impairment 3, 1
Assessment of episodic memory is crucial, as this is the most characteristic domain for patients who later progress to Alzheimer's disease 1
Evaluation of other cognitive domains, including executive functions, speech, spatial skills, and attention, is necessary to determine the pattern of impairment 1

The American Geriatrics Society recommends determining the degree of functional impairment using validated scales such as Functional Activities Questionnaire (FAQ) 1
The distinction between mild cognitive impairment (MCI) and dementia hinges on whether basic activities of daily living (ADL) are preserved—MCI patients have mild disturbances in complex tasks (instrumental ADL) but preserved basic ADL 3, 1

The American Heart Association recommends evaluating history of stroke or transient ischemic attack, hypertension, hyperlipidemia, and diabetes, as these are risk factors for both vascular cognitive impairment and peripheral neuropathy 1, 4
Multiple vascular risk factors dramatically increase stroke risk and can cause both cognitive decline and neurological symptoms 4

The American College of Radiology recommends performing brain MRI (or CT if MRI contraindicated) to exclude vascular lesions, tumors, hydrocephalus, hemorrhages, and structural abnormalities 1
MRI may reveal medial temporal lobe atrophy (marker of Alzheimer's disease) or vascular lesions contributing to cognitive decline 1

The American Psychiatric Association recommends that first major psychiatric episodes at advanced age, including new depression or anxiety, warrant comprehensive cognitive assessment as they may signal underlying dementia 2, 5
Mixed dementia (vascular plus Alzheimer's) is extremely common in elderly patients and can present with both cognitive and neurological symptoms 4

The National Institute on Aging recommends conducting serial cognitive assessments using the same instrument at intervals of at least 6 months to reduce practice effect and document progressive decline 1
Objective evidence of progressive cognitive decline over time is essential for establishing diagnostic accuracy 1

The American Academy of Neurology recommends initiating B12 replacement immediately if vitamin B12 deficiency is confirmed, as this is a reversible cause of both cognitive impairment and peripheral neuropathy 1
The American Heart Association recommends monitoring and aggressively managing vascular risk factors (hypertension, diabetes, hyperlipidemia), as they impact dementia progression 1, 4
The American Academy of Neurology recommends considering memantine for vascular cognitive impairment in individual patients 1
Intensive statin therapy and antiplatelet therapy for secondary stroke prevention if TIA/stroke history present 4
The Alzheimer's Association recommends ensuring assessment of caregiver needs in education, support, and respite services if mild cognitive impairment is diagnosed 1
Consider referral to specialists (neurologist, geriatrician, neuropsychologist) for atypical presentations, rapid progression, or complex symptoms 1
The American Academy of Neurology recommends cholinesterase inhibitors (donepezil) for mild to moderate dementia to improve cognitive function and activities of daily living 4
Memantine for moderate to severe dementia to improve daily functioning and cognitive performance 4